The Role of Size in Development of Mucosal Liposome-Lipopeptide Vaccine Candidates Against Group A < (IMAGE)

Bentham Science Publishers

The Role of Size in Development of Mucosal Liposome-Lipopeptide Vaccine Candidates Against Group A <

Caption

Group A Streptococcus (GAS), or Streptococcus pyogenes is an exclusivel y human Gram-positive pathogenic bacteria. A delay in treatment of GAS infection often lead to severe diseases such as rheumatic heart disease which attributes to hundreds of thousands deaths annually. For the past few decades, the quest for a commercial GAS vaccine has been futile mainly due to the presence of multiple GAS serotypes (more than 200).

Credit

Khairunnisa A. Ghaffar et al , Bentham Science Publishers

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.